Vancouver, BC - January 27, 2026 - PRESSADVANTAGE - AllScale, the leading non-custodial stablecoin neobank built for ...

SHENZHEN, GUANGDONG, CHINA, January 16, 2026 /EINPresswire.com/ -- As home wellness becomes a key component of global ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

The United States Consumer Product Safety Commission has announced a recall for a piece of exercise equipment due to fire ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

(WHTM) — Approximately 47,000 treadmills have been recalled nationwide. According to the U.S. Consumer Product Safety ...

Over the past five years, Novavax ( NVAX 6.01%), a vaccine maker, lost more than 90% of its market value. Though it succeeded ...

Security is a prerequisite for the application and development of LLM technology. Only by addressing security risks when integrating LLMs can businesses ensure healthy and sustainable growth. NSFOCUS ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments.

Tens of thousands of home treadmills sold nationwide are being recalled after reports that loose power cords can overheat and ...

Novavax’s president and CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a recent conference.

This recall involves Matrix Retail models T30, TF30, T50, TF50, and T75 treadmills, and Vision models T9800, TF20, T40, and ...